Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if used to treat acute asthma attacks, calling it the first major advance for this aspect of the disease in 50 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback